Biological variation in HBA1c predicts risk of retinopathy and nephropathy in type 1 diabetes [8] (multiple letters)

Diabetes Care

Volumn 28, Issue 1, 2005, Pages 233-235

  Genuth, Saul ^a,b   Lachin, John M ^c   Nathan, David M ^d   Chalew, Stuart A ^e,f,g   Hempe, James M ^f,g   McCarter, Robert J ^h  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e CHILDREN S HOSPITAL   (United States)

^f LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g The Research Institute for Children at Children's Hospital New Orleans   (United States)

^h CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; DIABETIC RETINOPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LETTER; METABOLIC RATE; REGRESSION ANALYSIS; RISK FACTOR; BLOOD; METABOLISM; NOTE; RISK ASSESSMENT; TIME;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; RISK ASSESSMENT; TIME FACTORS;

EID: 21644477869     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.1.233     Document Type: Letter

References (0)